DNAPrint Genomics (DNAG) Stock Price, News & Analysis

Company Overview

DNAPrint Genomics, Inc. is a molecular diagnostics and genetic testing company that specializes in ancestry inference and phenotypic trait prediction. The company offers direct-to-consumer and business-to-business services that analyze specific genetic markers to generate personalized reports on ancestral origins, physical characteristics and other inherited traits.

Utilizing proprietary genotyping arrays and bioinformatics algorithms, DNAPrint Genomics processes DNA samples collected via non-invasive swabs. Customers receive detailed insights into ancestral breakdowns across global populations as well as predictions related to traits such as eye color, hair pigmentation and other genetically influenced features.

Founded in 2001 and headquartered in South Florida, DNAPrint Genomics was among the first firms to offer automated ancestry and phenotype testing directly to consumers. While originally focused on the North American market, the company’s services have also been made available through select international distributors. Publicly traded on the OTCMKTS under the symbol DNAG, DNAPrint Genomics continues to support academic research collaborations and custom genetic testing projects alongside its consumer offerings.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DNAG Stock Analysis - Frequently Asked Questions

How do I buy shares of DNAPrint Genomics?

Shares of DNAG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of DNAPrint Genomics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DNAPrint Genomics investors own include Editas Medicine (EDIT), Pacira BioSciences (PCRX), BioStem Technologies (BSEM), Berkshire Hathaway (BRK.B), Bristol Myers Squibb (BMY), Bitwise Crypto Industry Innovators ETF (BITQ) and Black Diamond Therapeutics (BDTX).

Company Calendar

• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:DNAG
• CIK: N/A
• Web: www.dnaprint.com
• Phone: (941) 366-3400
• Fax: 941-952-9770
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.47